Your Sorted CME/CE Activities

PAH-Associated CTD: A Case for Differentiating SSc and SLE
AMA/ANCC/ACPE Activity - Lecture Library Slide Set
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Patients seen in a typical rheumatology practice are at higher risk of PAH secondary to their conditions. Rheumatologists should maintain a high index of suspicion for PAH in their patients with systemic sclerosis and other mixed connective tissue disorders. Emerging evidence suggests that two of the most prevalent CTDs, systemic sclerosis (SSc) and systemic lupus erythematosus (SLE), should be regarded as separate diseases due to their different etiologies, prognoses, and therapeutic responses. This slide kit will present insights into the different pathophysiological processes and management of patients with SSc and SLE-PAH, as well as recommendations for routine screening, risk factors, diagnosis, management, and ongoing monitoring of patients in a rheumatology practice for PAH.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.
James Seibold, MD, FACP, FACR
James Seibold, MD, FACP, FACR
President
Scleroderma Research Consultants LLC

Virginia Steen, MD
Virginia Steen, MD
Professor of Medicine
Chief, Division of Rheumatology
Georgetown University School of Medicine







20
Supported by independent educational grants from United Therapeutics Corporation, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson

Launch Date: April 13, 2022
Release Date: February 1, 2022
Expiration Date: March 31, 2023

March 31, 2023
Mini Module
7330
SSLectureLibrary22_WebBannerPAH(1150).gif
Pulmonology